UngTerapi ApS
CVR number: 38749463
Kvægtorvsgade 1, 1710 København V
admin@ungterapi.dk
tel: 40817127
https://ungterapi.dk
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 889.19 | 1 775.47 | 2 285.48 | 3 909.02 | 3 320.91 |
| Employee benefit expenses | -1 370.13 | -1 208.36 | -1 562.46 | -3 004.28 | -3 479.35 |
| Total depreciation | -1.99 | -29.90 | -29.90 | -29.90 | -29.74 |
| EBIT | 517.06 | 537.22 | 693.12 | 874.84 | - 188.18 |
| Other financial income | 15.89 | 92.82 | 58.28 | 77.01 | |
| Other financial expenses | -0.18 | -0.11 | -1.73 | -3.27 | -1.50 |
| Pre-tax profit | 516.88 | 553.00 | 784.22 | 929.85 | - 112.66 |
| Income taxes | - 113.95 | - 123.01 | - 172.75 | - 205.58 | 23.42 |
| Net earnings | 402.93 | 429.99 | 611.46 | 724.26 | -89.24 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 147.51 | 117.61 | 87.71 | 57.81 | 28.07 |
| Tangible assets total | 147.51 | 117.61 | 87.71 | 57.81 | 28.07 |
| Other receivables | 207.75 | 213.18 | |||
| Investments total | 207.75 | 213.18 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 133.57 | 73.51 | 38.38 | 11.40 | 115.54 |
| Current amounts owed by group member comp. | 208.23 | 122.95 | 1 521.94 | 2 132.67 | 1 062.78 |
| Prepayments and accrued income | 5.80 | 40.45 | 32.89 | 80.40 | |
| Current other receivables | 0.31 | 34.76 | |||
| Current deferred tax assets | 27.48 | ||||
| Short term receivables total | 341.81 | 202.58 | 1 635.53 | 2 176.95 | 1 286.20 |
| Cash and bank deposits | 375.42 | 724.84 | 56.01 | 18.31 | 11.03 |
| Cash and cash equivalents | 375.42 | 724.84 | 56.01 | 18.31 | 11.03 |
| Balance sheet total (assets) | 1 072.48 | 1 258.20 | 1 779.24 | 2 253.07 | 1 325.30 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Share premium account | 40.94 | 40.94 | |||
| Shares repurchased | 395.00 | 600.00 | 900.00 | ||
| Retained earnings | - 398.27 | 4.66 | - 124.42 | - 412.96 | 311.30 |
| Profit of the financial year | 402.93 | 429.99 | 611.46 | 724.26 | -89.24 |
| Shareholders equity total | 490.59 | 525.58 | 1 137.04 | 1 261.30 | 272.06 |
| Provisions | 7.78 | 7.37 | 5.42 | 2.31 | |
| Non-current other liabilities | 26.02 | ||||
| Non-current liabilities total | 26.02 | ||||
| Current loans from credit institutions | 55.32 | 393.25 | |||
| Advances received | 91.43 | 118.27 | 19.40 | ||
| Current trade creditors | 125.92 | 152.19 | 228.75 | 296.24 | 168.49 |
| Current owed to participating | 16.96 | 16.96 | 18.67 | 19.42 | 19.89 |
| Short-term deferred tax liabilities | 106.17 | 123.42 | 174.71 | 383.40 | 6.38 |
| Other non-interest bearing current liabilities | 207.61 | 314.40 | 214.65 | 215.68 | 465.23 |
| Current liabilities total | 548.08 | 725.25 | 636.78 | 989.46 | 1 053.24 |
| Balance sheet total (liabilities) | 1 072.48 | 1 258.20 | 1 779.24 | 2 253.07 | 1 325.30 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.